Cowealth Medical Holding Co (ROCO:4745) Cyclically Adjusted Revenue per Share: NT$63.28 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4745 Cowealth Medical Holding Co Ltd ROCO:4745
52 GF Score
Price NT$10.90
GF Value NT$12.99
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cowealth Medical Holding Co Cyclically Adjusted Revenue per Share?

Cowealth Medical Holding Co ROCO:4745 +4.81% 52 Cyclically Adjusted Revenue per Share is NT$63.28 as of Dec. 2025. GuruFocus rates ROCO:4745 with a GF Score™ of 52/100 and a GF Value™ of NT$12.99 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cowealth Medical Holding Co's adjusted revenue per share for the three months ended in Dec. 2025 was NT$7.384. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$63.28 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Cowealth Medical Holding Co's average Cyclically Adjusted Revenue Growth Rate was 0.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cowealth Medical Holding Co was 10.60% per year. The lowest was 3.10% per year. And the median was 7.20% per year.

As of today (2026-08-01), Cowealth Medical Holding Co's current stock price is NT$10.90. Cowealth Medical Holding Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was NT$63.28. Cowealth Medical Holding Co's Cyclically Adjusted PS Ratio of today is 0.17.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cowealth Medical Holding Co was 0.74. The lowest was 0.21. And the median was 0.42.


Cowealth Medical Holding Co  (ROCO:4745) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cowealth Medical Holding Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=10.90/63.28
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cowealth Medical Holding Co was 0.74. The lowest was 0.21. And the median was 0.42.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cowealth Medical Holding Co Cyclically Adjusted Revenue per Share Related Terms


Cowealth Medical Holding Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cowealth Medical Holding Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cowealth Medical Holding Co Cyclically Adjusted Revenue per Share Chart

Cowealth Medical Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.29 57.74 61.46 63.16 63.28

Cowealth Medical Holding Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.16 63.56 63.81 63.95 63.28

ROCO:4745 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Cowealth Medical Holding Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cowealth Medical Holding Co Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cowealth Medical Holding Co's Cyclically Adjusted PS Ratio falls into.


ROCO:4745
52GF Score
Cowealth Medical Holding Co Ltd ROCO:4745
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cowealth Medical Holding Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cowealth Medical Holding Co's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=7.384/324.0540*324.0540
=7.384

Current CPI (Dec. 2025) = 324.0540.

Cowealth Medical Holding Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 9.504 238.132 12.933
201606 9.548 241.018 12.837
201609 8.518 241.428 11.433
201612 9.478 241.432 12.722
201703 8.777 243.801 11.666
201706 8.177 244.955 10.817
201709 9.674 246.819 12.701
201712 10.542 246.524 13.857
201803 10.998 249.554 14.281
201806 12.452 251.989 16.013
201809 13.125 252.439 16.848
201812 12.470 251.233 16.084
201903 13.977 254.202 17.818
201906 16.755 256.143 21.197
201909 14.022 256.759 17.697
201912 14.727 256.974 18.571
202003 11.472 258.115 14.403
202006 17.328 257.797 21.782
202009 14.059 260.280 17.504
202012 18.864 260.474 23.469
202103 14.463 264.877 17.694
202106 18.934 271.696 22.583
202109 16.360 274.310 19.327
202112 16.230 278.802 18.864
202203 17.499 287.504 19.724
202206 18.276 296.311 19.987
202209 18.833 296.808 20.562
202212 18.069 296.797 19.728
202303 15.251 301.836 16.374
202306 16.832 305.109 17.877
202309 15.206 307.789 16.010
202312 14.700 306.746 15.529
202403 13.508 312.332 14.015
202406 13.242 314.175 13.658
202409 14.077 315.301 14.468
202412 13.226 315.605 13.580
202503 10.256 319.799 10.392
202506 10.432 322.561 10.480
202509 9.926 324.800 9.903
202512 7.384 324.054 7.384

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$63.28 mean?
Cowealth Medical Holding Co (ROCO:4745) has a Cyclically Adjusted Revenue per Share of NT$63.28 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cowealth Medical Holding Co and its competitors.
Is Cowealth Medical Holding Co's Cyclically Adjusted Revenue per Share too high?
Cowealth Medical Holding Co's current Cyclically Adjusted Revenue per Share is NT$63.28. Overall, Cowealth Medical Holding Co has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Cowealth Medical Holding Co's Cyclically Adjusted Revenue per Share of NT$63.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cowealth Medical Holding Co and its competitors. Cowealth Medical Holding Co's current Cyclically Adjusted Revenue per Share is NT$63.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$12.99, compared to a current price of NT$10.90 — trading 16.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$63.28. Cowealth Medical Holding Co's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current Cyclically Adjusted Revenue per Share is NT$63.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be undervalued. The current stock price of NT$10.90 is trading 16.1% below its estimated GF Value™ of NT$12.99. GuruFocus considers Cowealth Medical Holding Co to be Modestly Undervalued.

Key valuation signals for ROCO:4745:

  • Cyclically Adjusted Revenue per Share: NT$63.28
  • GF Value™: NT$12.99 vs. price of NT$10.90 (16.1% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cowealth Medical Holding Co Business Description

Address North Sound Road, Suite 102, Cannon Place, P.O. Box 712, George Town, Grand Cayman, CYM, KY1-9006
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
52GF Score

Get the complete analysis for ROCO:4745

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.90
Price
NT$12.99
GF Value